Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
France
Gustave Roussy, Villejuif Age range
18 Years and older
Last updated December 2025